Hypersexual behavior is a concept that is not included in the DSM-5, although it is encountered frequently in clinical practice. Cumulative evidence shows that childhood sexual abuse can play a significant role in hypersexuality cases. In this study, female patients with hypersexuality were retrospectively analyzed in terms of sociodemographic and clinical variables in 2020. 21 patients were diagnosed with hypersexual disorder according to Kafka’s proposed criteria. The mean age of the patients was 36.1 ± 9.0. Most of the patients had a history of sexual trauma. The most significant focus of this study was the diagnostic conversion from bipolar affective disorder to post-traumatic stress disorder. Post-traumatic stress symptoms directly affect hypersexual behavior through the mediation of depression, shame, and guilt. It is crucial to avoid assessing hypersexuality as a categorical symptom and pathological at first, and patients should be evaluated with their sociocultural aspects.
Obsessive-compulsive symptoms induced by clozapine negatively affect treatment compliance. In some studies, clonazepam was shown to be beneficial in obsessive-compulsive disorder. However, in literature there are case reports of life-threatening complications associated with the combined use of clozapine and benzodiazepines. In this article, the efficacy and safety of the clonazepam augmentation were discussed in two patients who had obsessive-compulsive symptoms induced by clozapine. No life-threatening complications were detected during the follow-up period of more than two years, and the patients benefited dramatically from the addition of clonazepam. In treatment-resistant patients, clonazepam can be used with close monitoring for obsessive-compulsive symptoms associated with atypical antipsychotics.
1 January 2023 in Dusunen Adam: Journal of Psychiatry and Neurological Sciences
Peripheral edema is characterized by interstitial fluid accumulation in the extravascular compartment. Use of psychotropic drugs can cause edema either directly or by causing systemic disease. We present a case of bilateral ankle edema reaching up to the middle of both legs in a 50-year-old female patient, which is considered to be a result of the use of mianserin 10 mg/day. Dramatic regression was observed in the patient???s edema 15 days after the cessation of mianserin. This is the second case in the literature that demonstrated peripheral edema associated with mianserin. Clinicians need to know about the management of edema and edema associated with the use of antidepressants.